Difference between revisions of "Team:Aachen/Entrepreneurship"

 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
−
{{Aachen}}
+
{{Aachen/header}}
 
<html>
 
<html>
  
 +
<div class="toppic" style="background-image: url(https://static.igem.org/mediawiki/2018/4/4a/T--Aachen--project_overview.jpg">
 +
</div>
  
 +
<section>
 +
<div class="container">
 +
<div class="row justify-content-center">
 +
<div class="col-sm-10"><h1>Entrepreneurship</h1>
 +
<hr>
 +
<h2>A lookout for the future</h2>
  
−
<div class="clear"></div>
+
<p>
 +
Because the occurrence of sleeping disorders, depression, Parkinson's disease, Alzheimer's and other neurodegenerative illnesses becomes more frequent in the modern society, there are huge economic and personal interests in detecting health irregularities as fast and distinct as possible. Likewise, the availability of this detection should be available equitably for everyone. A major part to accomplish this goal is minimizing the coasts of health measurements and proliferate distribution. With MELASENSE it is possible to measure melatonin content for less than six euro <sup><a href="# formel ">[1]</a></sup> when our device is built in mass production. So even people with a lower income could lower the risk of an unseen illness, which could cause to absolute unfitness for work, so they lose their chance of a better life through using their skills at their work.</p>
  
−
 
−
 
−
<div class="column full_size">
 
−
 
−
<h1>Entrepreneurship</h1>
 
−
 
−
</div>
 
−
 
−
<div class="column two_thirds_size">
 
−
<h3>Best Supporting Entrepreneurship Special Prize</h3>
 
 
<p>
 
<p>
−
In previous years, iGEM had an entrepreneurship track. Teams were encouraged to build projects and focus on commercializing their work. We have now moved to an award as the best work in this area may come from teams who are not solely focused on entrepreneurship.  
+
While neurodegenerative illnesses matter more for elderly people, the risks of depression and sleeping disorders are even important for students. So, an age-dependent allocation could be an option to get more consolation of the population. But also, a progression for a gadget that could measure the hormone concentration overnight is imaginable.</p>
−
</p>
+
<p>
−
 
+
Because no laboratory is necessary for the measurement, even regions with a low populousness or a lack of infrastructure could profit from our device. This would be a huge asset for healthcare and infrastructure. </p>
−
<p>The Best Supporting Entrepreneurship award recognizes exceptional effort to build a business case and commercialize an iGEM project. This award is open to all teams to show that entrepreneurship is something all teams can aspire to do with their project. This award can go to an new project, or to a previous project that a team aimed to commercialize. Have you filed a provisional patent on your project/device/process? Have you raised money to build and ship products? Have you pitched your idea to investors and received money? As always in iGEM, the aim is to impress the judges!
+
<p>
−
 
+
Because not only melatonin is released in salvia, but also other hormones including steroid ones, assays for lots of hormones could be developed, maybe with different attachments, by more working hours and capital expenditure. Also, an alternative system for doping tests could be designed after the MELASENSE model. <sup><a href="# steroids ">[2]</a></sup></p>
 +
<p>
 +
It could be possible to go one step further with integrate probes into mobile advices and conserve them until the measurement. An app, that shows the patients their alteration of hormone concentration by comparison of the average hormone incidence for their stage of life would be also conceivable.</p>
 +
<p>
 +
The market for health devices grows and currently there is no prospect of an end. To place it in a Growth-share matrix, we would place our advice in the question mark corner on a high level at the ordinate. There are lot of options for segmentation too, so this advice or parts of it could evolve to new question marks.<br>
 +
So there are lot of points, why an advancement of MELASENSE is interesting for investors and populace.
 
<br><br>
 
<br><br>
−
To compete for the <a href="https://2018.igem.org/Judging/Awards">Best Supporting Entrepreneurship prize</a>, please describe your work on this page and also fill out the description on the <a href="https://2018.igem.org/Judging/Judging_Form">judging form</a>.
+
<h3 id="footnote-label">
−
<br><br>
+
References
−
You must also delete the message box on the top of this page to be eligible for this prize.
+
</h3>
−
</p>
+
<hr>
−
</p>
+
<ol>
−
</div>
+
<li id="formel"><figure class="floated-m">
−
 
+
<img src="https://static.igem.org/mediawiki/2018/5/52/T--Aachen--calculation.jpg" class="img-fluid"
−
<div class="column third_size">
+
alt="our formula">
−
<div class="highlight decoration_A_full">
+
</figure> <br></p>
−
<h3>Inspiration</h3>
+
<p><li id="steroids"> Vining, R.F., McGinley, R. (2009)
−
<p>You can look at what other teams did to get some inspiration! <br />
+
−
Here are a few examples:</p>
+
</div>
−
<ul>
+
</div>
−
<li><a href="https://2016.igem.org/Team:Sydney_Australia">2016 Sydney Australia</a></li>
+
</div>
−
<li><a href="https://2016.igem.org/Team:Pasteur_Paris">2016 Pasteur Paris</a></li>
+
</section>
−
<li><a href="https://2014.igem.org/Team:UCC_Ireland">2014 UCC Ireland</a></li>
+
−
<li><a href="https://2014.igem.org/Team:Imperial">2014 Imperial College London</a></li>
+
−
</ul>
+
−
</div>
+
−
</div>
+
−
 
+
−
 
+
−
 
+
−
<div class="clear"></div>
+
−
 
+
−
<div class="column full_size">
+
−
<h3>Patents and intellectual property</h3>
+
−
 
+
−
<p>
+
−
If your team is seriously considering commercializing and looking into building a company after the competition, you may want to look at how you are going to protect your work and secure investment. Investors will usually require some form of intellectual protection, so you may want to investigate how to apply for a patent or provisional patent in your country and region before disclosing your project at iGEM. Remember that you can only be evaluated in iGEM based on what you share on your wiki and at the Jamboree, so any work you don't present can't count towards your project. </p>
+
−
 
+
−
<p>This is an area where we are different as we care about sharing, openness and contributing to the community and investors don't always agree with these values. It is up to you and your team to decide what to do. Remember that most universities have a commercialization department and that you can talk to them before coming to a decision.
+
−
</p>  
+
−
</div>
+
−
 
+
−
<div class="clear"></div>
+
−
 
+
−
 
+
 
</html>
 
</html>
 +
{{Aachen/footer}}

Latest revision as of 17:43, 18 November 2018

Entrepreneurship

A lookout for the future

Because the occurrence of sleeping disorders, depression, Parkinson's disease, Alzheimer's and other neurodegenerative illnesses becomes more frequent in the modern society, there are huge economic and personal interests in detecting health irregularities as fast and distinct as possible. Likewise, the availability of this detection should be available equitably for everyone. A major part to accomplish this goal is minimizing the coasts of health measurements and proliferate distribution. With MELASENSE it is possible to measure melatonin content for less than six euro [1] when our device is built in mass production. So even people with a lower income could lower the risk of an unseen illness, which could cause to absolute unfitness for work, so they lose their chance of a better life through using their skills at their work.

While neurodegenerative illnesses matter more for elderly people, the risks of depression and sleeping disorders are even important for students. So, an age-dependent allocation could be an option to get more consolation of the population. But also, a progression for a gadget that could measure the hormone concentration overnight is imaginable.

Because no laboratory is necessary for the measurement, even regions with a low populousness or a lack of infrastructure could profit from our device. This would be a huge asset for healthcare and infrastructure.

Because not only melatonin is released in salvia, but also other hormones including steroid ones, assays for lots of hormones could be developed, maybe with different attachments, by more working hours and capital expenditure. Also, an alternative system for doping tests could be designed after the MELASENSE model. [2]

It could be possible to go one step further with integrate probes into mobile advices and conserve them until the measurement. An app, that shows the patients their alteration of hormone concentration by comparison of the average hormone incidence for their stage of life would be also conceivable.

The market for health devices grows and currently there is no prospect of an end. To place it in a Growth-share matrix, we would place our advice in the question mark corner on a high level at the ordinate. There are lot of options for segmentation too, so this advice or parts of it could evolve to new question marks.
So there are lot of points, why an advancement of MELASENSE is interesting for investors and populace.

References

  1. our formula

  2. Vining, R.F., McGinley, R. (2009)